R. Payne

  • 2261 Citations
  • 29 h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where R. Payne is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Friedreich Ataxia Medicine & Life Sciences
Mitochondrial Form Creatine Kinase Medicine & Life Sciences
Mitochondria Medicine & Life Sciences
Proteins Medicine & Life Sciences
Cardiomyopathies Medicine & Life Sciences
Mitochondrial Proteins Medicine & Life Sciences
Creatine Kinase Medicine & Life Sciences
Heart Failure Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 1990 2016

Pediatric Heart Network Prairieland Consortium

Payne, R., Cnota, J., Krawczeski, C. D. & Payne, R.

National Institutes of Health

9/1/116/30/16

Project: Research project

Acute Kidney Injury
Pediatrics
Cardiopulmonary Bypass
Biomarkers
Point-of-Care Systems
Heart Failure
Heart Diseases
Research
Therapeutics
Young Adult
Friedreich Ataxia
Trans-Activators
Mitochondria
Proteins
Cell Culture Techniques

Publications 1989 2019

  • 2261 Citations
  • 29 h-Index
  • 68 Article
  • 1 Conference article
Embolism
Anticoagulants
Heart Diseases
Pediatrics
Safety

The current state of biomarker research for Friedreich's ataxia: A report from the 2018 FARA biomarker meeting

Blair, I. A., Farmer, J., Hersch, S., Larkindale, J., Lynch, D. R., Napierala, J., Napierala, M., Payne, R. & Subramony, S. H., Jan 1 2019, In : Future Science OA. 5, 6, FSO398.

Research output: Contribution to journalArticle

Open Access
Friedreich Ataxia
Biomarkers
Research
Disease Progression
Serum
3 Citations (Scopus)

Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial

Pediatric Heart Network Investigators, Jul 1 2018, In : American Heart Journal. 201, p. 1-8 8 p.

Research output: Contribution to journalArticle

udenafil
Exercise
Fontan Procedure
Safety
Low Cardiac Output
21 Citations (Scopus)

Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model

Martin, A. S., Abraham, D. M., Hershberger, K. A., Bhatt, D. P., Mao, L., Cui, H., Liu, J., Liu, X., Muehlbauer, M. J., Grimsrud, P. A., Locasale, J. W., Payne, R. & Hirschey, M. D., Jul 20 2017, In : JCI insight. 2, 14

Research output: Contribution to journalArticle

Open Access
Sirtuin 3
Nicotinamide Mononucleotide
Friedreich Ataxia
Cardiomyopathies
Energy Metabolism
1 Citation (Scopus)

Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's Ataxia cardiomyopathy

Stram, A. R., Wagner, G. R., Fogler, B. D., Pride, P. M., Hirschey, M. D. & Payne, R., May 1 2017, In : PLoS One. 12, 5, e0178354.

Research output: Contribution to journalArticle

Friedreich Ataxia
Acetylation
Mitochondrial Proteins
cardiomyopathy
acetylation